Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Cells|July 12, 2024
Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against GlioblastomaTrang T T Nguyen, Qiuqiang Gao, Jeong-Yeon Mun, et al.
Frontiers in Cell and Developmental Biology|December 13, 2021
ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc ExpressionAnnika Dwucet, Maximilian Pruss, Qiyu Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2010
Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancerByoung Heon Kang, Markus D Siegelin, Janet Plescia, et al.
Oncogenesis|November 30, 2017
The effects of PI3K-mediated signalling on glioblastoma cell behaviourJulia Langhans, Lukas Schneele, Nancy Trenkler, et al.
Scientific Reports|May 6, 2020
The limitations of targeting MEK signalling in Glioblastoma therapyKarthika D Selvasaravanan, Nicole Wiederspohn, Amina Hadzalic, et al.
Plos One|June 30, 2015
A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma TherapyStephanie Ströbele, Matthias Schneider, Lukas Schneele, et al.
Expert Opinion on Drug Discovery|August 23, 2022
Unblinding the watchmaker: cancer treatment and drug design in the face of evolutionary pressureSophia Konig, Hannah Strobel, Michael Grunert, et al.
Biomedicines|June 10, 2020
Considering the Experimental use of Temozolomide in Glioblastoma ResearchVerena J Herbener, Timo Burster, Alicia Goreth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2022
Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in GlioblastomaTrang T T Nguyen, Enyuan Shang, Salveena Schiffgens, et al.
Cancer Research|May 20, 2017
Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic ResponsesGeorg Karpel-Massler, Chiaki Tsuge Ishida, Elena Bianchetti, et al.
Pageof 9